Shield Therapeutics plc

STX.L · LSE
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents£10,814£5,608£6,407£10,941
Short-Term Investments£0£0£0£0
Receivables£23,693£20,164£12,421£8,797
Inventory£6,748£4,520£3,192£2,513
Other Curr. Assets£108£0£0£2,273
Total Curr. Assets£41,363£30,293£22,020£24,524
Property Plant & Equip (Net)£228£298£415£528
Goodwill£0£0£0£0
Intangibles£19,508£14,507£13,766£16,863
Long-Term Investments£730£798£791£0
Tax Assets£0£0-£13,766£0
Other NC Assets£270£0£13,766-£3,635
Total NC Assets£20,736£15,603£14,971£13,756
Other Assets£0£0£0£0
Total Assets£62,099£45,896£36,992£38,280
Liabilities
Payables£16,098£18,515£0£4,049
Short-Term Debt£99£156£231£382
Tax Payable£58£0£0£96
Deferred Revenue£0£0£0£0
Other Curr. Liab.£33,752£7,377£20,765£6,247
Total Curr. Liab.£50,007£26,048£20,996£10,774
LT Debt£26,949£20,899£15,568£15,755
Deferred Rev, NC£0£0£0£0
Deferred Tax Liab, NC£0£0£0£0
Other NC Liab.£0£0£0-£42
Total NC Liab.£26,949£20,899£15,568£15,713
Other Liabilities£0£0£0£0
Cap. Leases£99£0£0£409
Total Liabilities£76,956£46,947£36,564£26,487
Equity
Pref Stock£0£0£0£0
Common Stock£19,908£15,896£11,875£11,775
Retained Earnings-£269,015-£172,954-£162,312-£149,267
AOCI-£8,887-£6,233-£6,368-£6,630
Other Equity£234,250£162,239£157,234£155,914
Total Equity-£14,857-£1,052£428£11,792
Supplemental Information
Minority Interest£0£0£0£0
Total Liab. & Tot. Equity£62,099£45,896£36,992£38,280
Net Debt£16,234£15,447£9,392£5,196